Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

688189.SS Net Margin

The Net Margin of Hunan Nucien Pharmaceutical Co Ltd (688189.SS) is 0.50%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

688189.SS Net Margin - Historical Value
Date Value
2023-12-31 0.50%
2022-12-31 -11.28%
2021-12-31 -24.38%
2020-12-31 12.22%
2019-12-31 9.02%
2018-12-31 7.64%
2017-12-31 7.80%
688189.SS Net Margin - Peers Comparison
Ticker Name Value
002550.SZ Changzhou Qianhong Biopharma Co Ltd 10.02%
002907.SZ Chongqing Pharscin Pharmaceutical Co Ltd 4.73%
600624.SS Shanghai Fudan Forward S&T Co Ltd 0.88%
300878.SZ Zhejiang Wecome Pharmaceutical Co Ltd -1.55%
603676.SS Tibet Weixinkang Medicine Co Ltd 16.18%
000908.SZ Hunan Jingfeng Pharmaceutical Co Ltd -32.75%
002349.SZ Jinghua Pharmaceutical Group Co Ltd 16.38%
300199.SZ Hybio Pharmaceutical Co Ltd -119.12%
300434.SZ Sichuan Goldstone Asia Pharmaceutical Inc 10.44%
603590.SS Beijing Konruns Pharmaceutical Co Ltd 16.35%
605177.SS Zhejiang East Asia Pharmaceutical Co Ltd 8.94%
603439.SS Guizhou Sanli Pharmaceutical Co Ltd 17.90%
603811.SS Zhejiang Cheng Yi Pharmaceutical Co Ltd 24.25%
300110.SZ Huaren Pharmaceutical Co Ltd 11.49%
300705.SZ Hunan Jiudian Pharmaceutical Co Ltd 13.68%
600851.SS Shanghai Haixin Group Co Ltd 14.04%
603538.SS Ningbo Menovo Pharmaceutical Co Ltd 0.95%
605116.SS Aurisco Pharmaceutical Co Ltd 22.92%
688513.SS Chengdu Easton Biopharmaceuticals Co Ltd 20.28%
002107.SZ Shandong Wohua Pharmaceutical Co Ltd 6.46%
603566.SS Pulike Biological Engineering Inc 13.93%
002644.SZ Lanzhou Foci Pharmaceutical Co Ltd 5.78%
300039.SZ Shanghai Kaibao Pharmaceutical Co Ltd 20.57%
300181.SZ Zhejiang Jolly Pharmaceutical Co Ltd 19.71%
300436.SZ Fujian Cosunter Pharmaceutical Co Ltd -82.46%
002118.SZ Jilin Zixin Pharmaceutical Industrial Co Ltd -828.71%
603222.SS Chimin Health Management Co Ltd -7.32%
688566.SS Jiangsu Jibeier Pharmaceutical Co Ltd 24.46%